EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression

Miyeong Kim, Jinpeng Liu, Yanquan Zhang, Ruixin Wang, Ryan Goettl, Jennifer Grasso, Derek B Allison, Chi Wang, Tianyan Gao, Xiaoqi Liu, Ka-Wing Fong

Journal of Clinical Investigation · 16.06.2025 · 135 (12)

DOI: 10.1172/jci185119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.06.2025. Verfasst von Miyeong Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Cancer Biology. Hauptthemen laut MEDLINE: E2F1 Transcription Factor, Ribosomal Protein S6 Kinases, 90-kDa, Tripartite Motif-Containing Protein 28, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Castration-resistant prostate cancer (CRPC) marks the advanced and lethal stage of prostate cancer (PCa). TRIM28, also known as KAP1, is a transcriptional regulator recently shown to promote CRPC cell proliferation and xenograft tumor growth. Nonetheless, knowledge gaps persist regarding the mechanisms underlying TRIM28 upregulation in CRPC as well as the genomic targets regulated by TRIM28. Here, we report that TRIM28 is a E2F1 target in CRPC. Using an integrated genomic approach, we have demonstrated that TRIM28 forms a positive feedback loop to promote the transcriptional activation and genomic function of E2F1 independent of retinoblastoma (Rb) status. Furthermore, we identified RSK1 as a kinase that directly phosphorylates TRIM28 at S473, and, as such, RSK1 drives the TRIM28/E2F1 feedback loop. Accordingly, pS473-TRIM28 promotes CRPC progression, which is mitigated by RSK inhibition. In summary, our study reveals a critical role of the RSK1–TRIM28–E2F1 axis in CRPC progression, which may be exploited as a vulnerability in treating Rb-deficient CRPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

E2F1 Transcription FactorRibosomal Protein S6 Kinases, 90-kDaTripartite Motif-Containing Protein 28Prostatic Neoplasms, Castration-ResistantFeedback, PhysiologicalNeoplasm ProteinsMaleHumansAnimalsMiceCell Line, TumorDisease Progression

Stichwörter der Autor:innen

Cell biologyEndocrinologyProstate cancer

Substanzen

E2F1 Transcription FactorRibosomal Protein S6 Kinases, 90-kDaTripartite Motif-Containing Protein 28E2F1 protein, humanTRIM28 protein, humanNeoplasm ProteinsRPS6KA1 protein, human

Autor:innen und Institutionen

  • Department of Toxicology and Cancer Biology.
  • Department of Biostatistics, College of Public Health.
  • Department of Pathology & Laboratory Medicine.
  • Department of Molecular and Cellular Biochemistry, and.
  • Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIH
  • V Foundation for Cancer Research
  • American Cancer Society
  • national institute of health

Zitieren

APA

Kim, M., Liu, J., Zhang, Y., Wang, R., Goettl, R., Grasso, J., Allison, D. B., Wang, C., Gao, T., Liu, X., & Fong, K. W. (2025). RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression. Journal of Clinical Investigation, 135(12). https://doi.org/10.1172/jci185119

Vancouver

Kim M, Liu J, Zhang Y, Wang R, Goettl R, Grasso J, et al. RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression. Journal of Clinical Investigation. 2025;135(12). doi:10.1172/jci185119

BibTeX
@article{Kim2025,
  author = {Kim, Miyeong and Liu, Jinpeng and Zhang, Yanquan and Wang, Ruixin and Goettl, Ryan and Grasso, Jennifer and Allison, Derek B and Wang, Chi and Gao, Tianyan and Liu, Xiaoqi and Fong, Ka-Wing},
  title = {RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {12},
  doi = {10.1172/jci185119}
}
Kostenlos starten →